Search & Analyze
Popular Searches
Divi's Laboratories Ltd.
Healthcare₹7,240.500.39%
24 Jul, 4:01 PM
CMP₹7,240.50
Mkt Cap₹1.94L Cr
P/E75.49
P/B11.57
ROE16.19%
52W High₹7,437.65
52W Low₹5,637.50
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
75.49
P/B Ratio
11.57
EV/EBITDA
48.23
Price/Sales
18.36
Dividend Yield (%)
0.41
EPS (TTM ₹)
96.73
Book Value (₹)
631.38
ROE (%)
16.19
ROCE (%)
21.51
ROA (%)
13.31
EBITDA Margin (%)
32.74
Net Profit Margin (%)
24.43
Debt/Equity
0.00
Current Ratio
4.12
Interest Coverage
142.17
Asset Turnover
0.54
Working Capital/Sales
1.16
Core EBITDA Growth (%)
18.91
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 895983 | 7767 | 7845 | 9360 | 10560 |
| Net Sales | 895983 | 7767 | 7845 | 9360 | 10560 |
| Total Income | 907573 | 8112 | 8184 | 9712 | 11067 |
| Total Expenditure | 507872 | 5398 | 5639 | 6391 | 7118 |
| Operating Profit | 399701 | 2714 | 2545 | 3321 | 3949 |
| Depreciation | 31151 | 343 | 378 | 402 | 463 |
| Exceptional Items | — | — | — | — | -74 |
| Profit Before Tax | 368350 | 2369 | 2163 | 2916 | 3388 |
| Tax | 72305 | 545 | 563 | 725 | 820 |
| Profit After Tax (PAT) | 296045 | 1824 | 1600 | 2191 | 2568 |
| EPS (₹) | 111.52 | 68.69 | 60.27 | 82.53 | 96.75 |
| Dividend Payout % | 1500 | 1500 | 1500 | 1500 | 1500 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 5309 | 53 | 53 | 53 | 53 |
| Reserves | 1167509 | 12714 | 13518 | 14916 | 16708 |
| Shareholders Funds | 1172818 | 12767 | 13571 | 14969 | 16761 |
| Total Debt | 0 | 0 | 0 | 2 | 0 |
| Total Liabilities | 1461913 | 14863 | 15937 | 17717 | 20878 |
| Total Assets | 1461913 | 14863 | 15937 | 17717 | 20878 |
| Book Value / Share | 441.8226 | 481.7736 | 512.1132 | 564.8679 | 632.4906 |
| Assets | 1461913 | 14863 | 15937 | 17717 | 20878 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 191180 | 2459 | 1261 | 1653 | 2738 |
| Investing Activities | -219492 | -2707 | -269 | -804 | -2219 |
| Financing Activities | -53244 | -797 | -799 | -799 | -804 |
| Net Cash Flow | -81556 | -1045 | 193 | 50 | -285 |
DIVISLAB
₹7,240.50
+0.39%